APA 6th Edition Canjuga, I., Mravak-Stipetić, M., Lončar, B. i Kern, J. (2010). The Prevalence of Systemic Diseases and Medications in Patients with Oral Lichen Planus. Acta stomatologica Croatica, 44 (2), 96-100. Preuzeto s https://hrcak.srce.hr/55643
MLA 8th Edition Canjuga, Ivana, et al. "The Prevalence of Systemic Diseases and Medications in Patients with Oral Lichen Planus." Acta stomatologica Croatica, vol. 44, br. 2, 2010, str. 96-100. https://hrcak.srce.hr/55643. Citirano 02.03.2021.
Chicago 17th Edition Canjuga, Ivana, Marinka Mravak-Stipetić, Božana Lončar i Josipa Kern. "The Prevalence of Systemic Diseases and Medications in Patients with Oral Lichen Planus." Acta stomatologica Croatica 44, br. 2 (2010): 96-100. https://hrcak.srce.hr/55643
Harvard Canjuga, I., et al. (2010). 'The Prevalence of Systemic Diseases and Medications in Patients with Oral Lichen Planus', Acta stomatologica Croatica, 44(2), str. 96-100. Preuzeto s: https://hrcak.srce.hr/55643 (Datum pristupa: 02.03.2021.)
Vancouver Canjuga I, Mravak-Stipetić M, Lončar B, Kern J. The Prevalence of Systemic Diseases and Medications in Patients with Oral Lichen Planus. Acta stomatologica Croatica [Internet]. 2010 [pristupljeno 02.03.2021.];44(2):96-100. Dostupno na: https://hrcak.srce.hr/55643
IEEE I. Canjuga, M. Mravak-Stipetić, B. Lončar i J. Kern, "The Prevalence of Systemic Diseases and Medications in Patients with Oral Lichen Planus", Acta stomatologica Croatica, vol.44, br. 2, str. 96-100, 2010. [Online]. Dostupno na: https://hrcak.srce.hr/55643. [Citirano: 02.03.2021.]
APA 6th Edition Canjuga, I., Mravak-Stipetić, M., Lončar, B. i Kern, J. (2010). Prevalencija sustavnih bolesti i lijekova u bolesnika s oralnim lihenom planusom. Acta stomatologica Croatica, 44 (2), 96-100. Preuzeto s https://hrcak.srce.hr/55643
MLA 8th Edition Canjuga, Ivana, et al. "Prevalencija sustavnih bolesti i lijekova u bolesnika s oralnim lihenom planusom." Acta stomatologica Croatica, vol. 44, br. 2, 2010, str. 96-100. https://hrcak.srce.hr/55643. Citirano 02.03.2021.
Chicago 17th Edition Canjuga, Ivana, Marinka Mravak-Stipetić, Božana Lončar i Josipa Kern. "Prevalencija sustavnih bolesti i lijekova u bolesnika s oralnim lihenom planusom." Acta stomatologica Croatica 44, br. 2 (2010): 96-100. https://hrcak.srce.hr/55643
Harvard Canjuga, I., et al. (2010). 'Prevalencija sustavnih bolesti i lijekova u bolesnika s oralnim lihenom planusom', Acta stomatologica Croatica, 44(2), str. 96-100. Preuzeto s: https://hrcak.srce.hr/55643 (Datum pristupa: 02.03.2021.)
Vancouver Canjuga I, Mravak-Stipetić M, Lončar B, Kern J. Prevalencija sustavnih bolesti i lijekova u bolesnika s oralnim lihenom planusom. Acta stomatologica Croatica [Internet]. 2010 [pristupljeno 02.03.2021.];44(2):96-100. Dostupno na: https://hrcak.srce.hr/55643
IEEE I. Canjuga, M. Mravak-Stipetić, B. Lončar i J. Kern, "Prevalencija sustavnih bolesti i lijekova u bolesnika s oralnim lihenom planusom", Acta stomatologica Croatica, vol.44, br. 2, str. 96-100, 2010. [Online]. Dostupno na: https://hrcak.srce.hr/55643. [Citirano: 02.03.2021.]
Sažetak Lichen planus is a chronic immunologic inflammatory disease that frequently involves oral mucosa. Systemic diseases and medications are considered to be precipitating factors in the development of oral lichen planus. Objective: The purpose of this study was to examine the prevalence of systemic diseases and medications in patients with oral lichen planus (OLP) and to determine possible causal relationship. Materials and methods: Retrospective data included medical records of 145 patients, 104 women and 41 men who were referred to the Department of Oral Medicine. All patients had clinical and histopathological criteria fulfilled for diagnosis of oral lichen planus. Data were collected for the period of two years (autumn 2007- autumn 2009). These data were compared with the prevalence of systemic diseases in patients with oral leukoplakia (LPL) and general Croatian population according to the national statistical register. The same comparison was made for the used medications. Obtained data were analyzed by use of χ2 test with level of significance p<0,05. Results: Systemic diseases associated with OLP were found in 77.9% of patients. The most frequent disease was hypertension. Frequency of systemic diseases between patients with OLP and LPL has shown statistically significant difference. Conclusion: Increased prevalence of hypertension among OLP patients in comparison to the prevalence in the general population can not be interpreted as the etiological factor for the development of OLP since hypertension is the most prevalent disease in general population.